Cardiac impairment in long COVID 1-year post-SARS-CoV-2 infection

CoverScan identified cardiac abnormalities in ~20%patients at 6 months, persisting in over half of those at 12 months following initial COVID-19 symptoms. Importantly, blood biomarkers were not as sensitive as MRI in identifying cardiac abnormalities, highlighting its utility in the clinical diagnosis and management of patients with multi-system conditions.